FilingSEC EDGAR8-K
Gain Therapeutics Announces CFO Resignation and Interim Appointment
· SEC accepted
StageManagement Change
Filing content
The company announced that CEO Gene Mack will serve as interim CFO effective October 1, following the resignation of its principal financial officer.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…